Acute megakaryoblastic leukemia overview

Jump to: navigation, search

Acute megakaryoblastic leukemia Microchapters

Home

Overview

Classification

Pathophysiology

Differentiating Acute megakaryoblastic leukemia from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute megakaryoblastic leukemia overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute megakaryoblastic leukemia overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute megakaryoblastic leukemia overview

CDC on Acute megakaryoblastic leukemia overview

Acute megakaryoblastic leukemia overview in the news

Blogs on Acute megakaryoblastic leukemia overview

Directions to Hospitals Treating Acute megakaryoblastic leukemia

Risk calculators and risk factors for Acute megakaryoblastic leukemia overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Acute megakaryoblastic leukemia (AMKL) is a form of leukemia where a majority of the blasts are megakaryoblastic.[1]

It is classified under M7 in the French-American-British classification.[2]

In the first three years of life megakaryoblastic leukemia is the most common type of leukemia in patients with Downs syndrome.[3]

References

  1. "Final Diagnosis -- Case 439". Retrieved 2008-03-08.
  2. "Acute Myeloid Leukemia - Signs and Symptoms".
  3. Hitzler JK. (2007) Acute megakaryoblastic leukemia in Down syndrome. Pediatr Blood Cancer. Dec;49(7 Suppl):1066-9. PMID: 17943965.

Linked-in.jpg